Benlysta Dosing Calculator

How Benlysta Dosing Is Calculated

Benlysta dosing varies significantly depending on the route of administration. The IV formulation is weight-based, requiring precise calculation of the belimumab concentration per kilogram of body weight. In contrast, the subcutaneous formulation utilizes a fixed-dose mechanism regardless of patient weight.

For subcutaneous administration, the calculation is straightforward, as the FDA-approved dosage is consistently 200 mg injected once weekly. This method bypasses the need for weight calculations but requires a different administration schedule compared to the IV induction and maintenance phases.

What Your Benlysta Dose Means

The calculated dose represents the estimated amount of belimumab required to safely and effectively treat SLE or Lupus Nephritis. This figure aims to ensure the therapeutic concentration is achieved without exceeding safety limits.

For IV Induction:

If your result falls into the induction category, you will administer the calculated dose at Weeks 0, 2, and 4. This loading phase rapidly establishes the drug's presence in the body to begin attacking the specific immune cells responsible for lupus symptoms.

For IV Maintenance:

Following induction, the same weight-based dose is administered every 4 weeks. This consistent schedule maintains the necessary plasma concentration to keep disease activity under control over the long term.

For SC Administration:

The fixed 200 mg weekly dose offers convenience for patients who prefer at-home administration. It eliminates the need for clinic visits for infusions after proper training.